Isolation, identification, and characterization of small bioactive peptides from Lactobacillus GG conditional media that exert both anti-gram-negative and Gram-positive bactericidal activity

Journal of Pediatric Gastroenterology and Nutrition

Volumn 49, Issue 1, 2009, Pages 23-30

  Lu, Ruiliang ^a,e   Fasano, Serena ^a,b   Madayiputhiya, Nandakumar ^c   Morin, Nicholas P ^d   Nataro, James ^d   Fasano, Alessio ^a  

^a Mucosal Biology Research Center   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Proteomic Core Facility

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e SCHOOL OF MEDICINE   (United States)

Author keywords

Antibacterial peptides; Diarrhea; Lactobacillus GG; Probiotics

Indexed keywords

ASPARAGINYLPROLYLSERYLARGINYLGLUTAMINYLGLUTAMYLARGINYLARGININE; GLYCYLLYSYLLEUCYLSERYLASPARAGINYLLYSINE; LEUCYLSERYLGLUTAMINYLLYSYLSERYLVALYLLYSINE; METHIONYLLEUCYLASPARAGINYLGLUTAMYLARGINYLVALYLLYSINE; PROBIOTIC AGENT; PROLYLASPARTYLGLUTAMYLASPARAGINYLLYSINE; TYROSYLTHREONYLARGINYLGLYCYLLEUCYLPROLYLMETHIONINE; UNCLASSIFIED DRUG; VALYLHISTIDYLTHREONYLALANYLPROLYLLYSINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CONTROLLED STUDY; DOSE RESPONSE; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; LACTOBACILLUS; LACTOBACILLUS GG; LIQUID CHROMATOGRAPHY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; THERMOSTABILITY;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CULTURE MEDIA, CONDITIONED; ESCHERICHIA COLI; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LACTOBACILLUS; PEPTIDES; PROBIOTICS; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI EAEC 042; LACTOBACILLUS; NEGIBACTERIA; POSIBACTERIA; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS;

EID: 67651071793     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181924d1e     Document Type: Article

References (21)

1. Nataro JP. Vaccines against diarrheal diseases. Semin Pediatr Infect Dis 2004;15:272-9.
2. O'Ryan M, Prado V, Pickering LK. A millennium update on pediatric diarrheal illness in the developing world. Semin Pediatr Infect Dis 2005;16:125-36.
3. Marano NN, Rossiter S, Stamey K, et al. The National Antimicrobial Resistance Monitoring System (NARMS) for enteric bacteria, 1996-1999: surveillance for action. J Am Vet Med Assoc 2000; 217:1829-30.
4. Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett 2006; 254:12-8.
5. The US Centers for Disease Control and Prevention (CDC). Outbreaks of Escherichia coli serotype O157:H7 infections in contaminated spinach. September 29 issue of the Morbidity and Mortality Weekly Report.
6. Mata L. Diarrheal disease as a cause of malnutrition. Am J Trop Med Hyg 1992;47:16-27.
7. Guandalini S. Probiotics for children: use in diarrhea. J Clin Gastroenterol 2006;40:244-8.
8. FAO/WHO. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria; 2001.
9. Santosa S, Farnworth E, Jones PJ. Probiotics and their potential health claims. Nutr Rev 2006;64:265-74.
10. Ljungh A, Wadstrom T. Lactic acid bacteria as probiotics. Curr Issues Intest Microbiol 2006;7:73-89.
11. Broekaert IJ, Walker WA. Probiotics as flourishing benefactors for the human body. Gastroenterol Nurs 2006;29:26-34.
12. Kreander A, Vuorela P, Tammela P. A rapid screening method for detecting active compounds against erythromicin-resistant bacterial strains of Finnish origin. Folia Microbiol 2005;50:487-93.
13. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66:365-78.
14. Metchnikoff, E. Essais optimistes. Paris. The prolongation of life. Optimistic studies. Translated and edited by P. Chalmers Mitchell. London: Heinemann; 1907.
15. Reid G, Jass J, Sebulsky MT, et al. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003;16:658-72.
16. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 2002;82:279-89.
17. Silva M, Jacobus NW, Deneke C, et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987;31:1231-3.
18. Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002; 277:50959-65.
19. Yan F, Cao H, Cover TL, et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007;132:562-75.
20. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 2003;55:27-55.
21. Dennehy PH. Active immunization in the United States: developments over the past decade. Clin Microbiol Rev 2001;14:872-908.